Semiautomated quantitative detection of loss of heterozygosity in the tumor suppressor gene p53. 1995

M Hahn, and S E Matzen, and J Serth, and A Pingoud
Justus-Liebig-Universität, Giessen, Germany.

The most frequently altered gene in diverse tumor types is the tumor suppressor gene p53. Typically, normal function is inactivated by point mutation of one allele and deletion of the other. Therefore, loss of heterozygosity (LOH) of intragenic polymorphic markers is a strong indication for p53 involvement in a cancerous lesion. This study shows that a highly polymorphic short tandem repeat (STR) within intron 1 of p53 is an excellent marker for quantitative evaluation of LOH in tumor samples, whose multicolor, fluorescently tagged PCR products are analyzed and quantitated on an automated DNA sequencer. The range of error was analyzed in detail. Discrete allelic profiles were obtained following amplification of DNA from microdissected cell samples of patients with urogenital tumors. By calculating qLOH, the relative allele ratio of a tumor compared with healthy tissue, a quantitative expression for the LOH is obtained. PCR-based tumor DNA typing using fluorescent STR primers and automated analysis provides an enhanced level of accuracy and sensitivity required for routine analysis in clinical practice, where large numbers of tumor samples have to be processed.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005456 Fluorescent Dyes Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. Flourescent Agent,Fluorescent Dye,Fluorescent Probe,Fluorescent Probes,Fluorochrome,Fluorochromes,Fluorogenic Substrates,Fluorescence Agents,Fluorescent Agents,Fluorogenic Substrate,Agents, Fluorescence,Agents, Fluorescent,Dyes, Fluorescent,Probes, Fluorescent,Substrates, Fluorogenic
D005782 Gels Colloids with a solid continuous phase and liquid as the dispersed phase; gels may be unstable when, due to temperature or other cause, the solid phase liquefies; the resulting colloid is called a sol.
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D014565 Urogenital Neoplasms Tumors or cancer of the UROGENITAL SYSTEM in either the male or the female. Genitourinary Cancer,Genitourinary Neoplasms,Urogenital Cancer,Genito-urinary Cancer,Genito-urinary Neoplasm,Neoplasms, Genitourinary,Neoplasms, Urogenital,Cancer, Genito-urinary,Cancer, Genitourinary,Cancer, Urogenital,Cancers, Genito-urinary,Cancers, Genitourinary,Cancers, Urogenital,Genito urinary Cancer,Genito-urinary Cancers,Genito-urinary Neoplasms,Genitourinary Cancers,Genitourinary Neoplasm,Neoplasm, Genito-urinary,Neoplasm, Genitourinary,Neoplasm, Urogenital,Neoplasms, Genito-urinary,Urogenital Cancers,Urogenital Neoplasm
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face

Related Publications

M Hahn, and S E Matzen, and J Serth, and A Pingoud
June 1995, Pathology, research and practice,
M Hahn, and S E Matzen, and J Serth, and A Pingoud
March 2000, The Journal of urology,
M Hahn, and S E Matzen, and J Serth, and A Pingoud
January 1996, Anticancer research,
M Hahn, and S E Matzen, and J Serth, and A Pingoud
April 1996, The Journal of urology,
M Hahn, and S E Matzen, and J Serth, and A Pingoud
September 2006, Vojnosanitetski pregled,
M Hahn, and S E Matzen, and J Serth, and A Pingoud
November 1989, Proceedings of the National Academy of Sciences of the United States of America,
M Hahn, and S E Matzen, and J Serth, and A Pingoud
April 2001, Journal of molecular medicine (Berlin, Germany),
M Hahn, and S E Matzen, and J Serth, and A Pingoud
May 1992, The New England journal of medicine,
M Hahn, and S E Matzen, and J Serth, and A Pingoud
June 1994, The Journal of laboratory and clinical medicine,
Copied contents to your clipboard!